Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Inventory: 2009-2025

Historic Inventory for Gyre Therapeutics (GYRE) over the last 3 years, with Sep 2025 value amounting to $8.9 million.

  • Gyre Therapeutics' Inventory rose 38.80% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 38.80%. This contributed to the annual value of $6.3 million for FY2024, which is 48.03% up from last year.
  • Gyre Therapeutics' Inventory amounted to $8.9 million in Q3 2025, which was down 0.08% from $8.9 million recorded in Q2 2025.
  • Gyre Therapeutics' 5-year Inventory high stood at $8.9 million for Q2 2025, and its period low was $4.3 million during Q4 2023.
  • Moreover, its 3-year median value for Inventory was $6.4 million (2024), whereas its average is $6.6 million.
  • Per our database at Business Quant, Gyre Therapeutics' Inventory tumbled by 30.07% in 2023 and then soared by 59.51% in 2025.
  • Over the past 4 years, Gyre Therapeutics' Inventory (Quarterly) stood at $6.1 million in 2022, then tumbled by 30.07% to $4.3 million in 2023, then soared by 48.03% to $6.3 million in 2024, then skyrocketed by 38.80% to $8.9 million in 2025.
  • Its last three reported values are $8.9 million in Q3 2025, $8.9 million for Q2 2025, and $7.9 million during Q1 2025.